Outsourcing drug discovery and development has become the key to making the entire drug research process more efficient. Over the past few years, pharmaceutical companies have realized their current format of doing all work in-house is unsustainable, given the constant challenge to reduce costs and increase efficiency. They have suffered decreased productivity, higher costs, and with the ongoing patent cliff, have realized something needs to change. The name of the game for drug research today is outsourcing [1].

Outsourcing makes it easier to access research capabilities and experts on demand, thereby empowering researchers. Other benefits include dramatically reduced costs, shortened development times, improved productivity and higher quality.

Outsourcing can increase productivity and bring higher quality products back to pharmaceutical companies.Outsourcing can improve productivity and bring higher quality products back to pharmaceutical companies [1].
Many companies maintain a core of scientists in-house, while making use of contract labs and academic institutions to outsource much of the actual work. By contracting to smaller specialist providers, large companies can tap into their knowledge pool and gain access to skills and techniques that would be financially impossible to maintain in house.  In one case study, Nitto Denko, a large technical corporation headquartered in Japan, realized 85% cost savings at their San Diego facility by outsourcing a project. Instead of paying $40,000 to synthesize a control compound, they paid only $5,000 to a vendor they located through Assay Depot, an online research exchange that connects scientists with companies offering services in a specialized area [2].

There can be challenges when it comes to outsourcing, but with awareness and proper management, they are easily overcome. Potential challenges include readjusting the mindset of the pharmaceutical company, focusing on mutual respect, collaboration and communication [3]. The setting of research timelines and deadlines is also of great importance. By having thorough project management with agreed upon deliverables and timing, previous barriers are removed, enabling innovative research and results for all parties involved.

So how does a pharmaceutical company find the right outsourcing partners? One popular route is to utilize online tools such as research exchanges, which can be thought of as a combination of Google and Amazon for research services. Research exchanges, such as Assay Depot, enable research scientists to rapidly drill down through thousands of global vendors to find the handful that can provide the exact custom service they need, when they need it. In fact, using these platforms, a researcher can take a compound from idea all the way through to the clinic, outsourcing every step in the process. Ultimately, they enable scientists to bring higher quality compounds to the clinic in a shorter period of time. In the modern pharmaceutical industry, that is the very definition of innovation.

References

1. https://www.assaydepot.com/files/depot-page/6621e6a2f96d473723e2118d6db1971a/Strategic_Outsourcing_AssayDepot_2013_16-19.pdf

2. https://www.assaydepot.com/files/depot-page/6621e6a2f96d473723e2118d6db1971a/Case_Study_Nitto_Denko.pdf

3. http://www.outsourcing-pharma.com/Preclinical-Research/Arrogance-and-animal-testing-the-hurdles-to-outsourcing?utm_source=RSS_text_news&utm_medium=RSS%2Bfeed&utm_campaign=RSS%2BText%2BNews

Posted 8:00 pm,

We recently talked about how Green Fluorescent Protein, restriction enzymes, and CRISPR are invaluable products of basic research. These investigations did not specifically go after a particular human ailment or disease, but were more directed towards enhancing our understanding of the world. These examples are just a few of the famous outcomes of basic research, […]

Read More...
Posted 8:00 pm,

The Fermanian School of Business and the Fermanian Business and Economic Institute held their annual Business Breakfast honoring the Dealmakers of the Year for 2014 on April 10th. These awards recognize individuals, firms, and collaborations that exemplify creativity, innovation, and ethical practices that create long term value for the business community in the San Diego […]

Read More...
Posted 8:00 pm,

Over the course of the last century we’ve had the age of antibiotics, the genetic revolution, transplantation and immunotherapy, each of which ushered in a raft of new therapies dramatically improving human health.  Now we enter the “Age of the Microbiome” in drug discovery, the scope of which potentially exceeds anything that has gone before […]

Read More...
Posted 8:15 am,

We invited Bob Evans, Senior Business Development & Marketing Director from one of our most trusted vendors Cambridge Biomedical to discuss onshoring versus offshoring and why you choose a domestic CRO for your bioanalytical assay needs? Offshoring is a term often heard within the CRO community from clients who seek to find the lowest cost […]

Read More...
Posted 8:00 pm,

There’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country. Many scientists are moving away from the large pharmaceutical companies, whether as a result of job layoffs or their desire to work in a smaller company setting, and are grouping together with new exciting […]

Read More...
Posted 8:00 pm,

Assay Depot released a press release announcing it raised $3 million in Series B Funds to “Grow Science as a Server” Platform. Assay Depot is often referred to as the “Amazon.com for scientists” and hopes to increase drug discovery efficiency. That way, scientists are able to “outsource everything but the genius” and spend their time […]

Read More...
Posted 8:00 pm,

Whenever it is announced that budgets must be tightened, it is often scientists performing basic research who are among the first to be called to justify their financial support. Everyone can usually agree that investigating a promising cancer or disease treatment deserves funding, but when it comes to a basic research program, an exploration of […]

Read More...
Posted 8:00 pm,

The increasing awareness of the scientific research community on the importance of open access and open science has given rise to a new funding source in the research world. While the rise of start-ups and the popularity of the start-up culture have given rise to crowdfunding, open access to scientific data has also aided the […]

Read More...
Posted 8:00 pm,

While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of potential rare disease drugs are difficult to conduct. Typical common disease clinical trials can select from a large pool of candidates. Rare disease clinical research has multiple disadvantages including having a smaller sample size, less […]

Read More...
Posted 8:00 pm,